Table 2.
Clinic/Genes | PEV | Partial PEV | Total PEV |
---|---|---|---|
Age | 12.80% | ||
FIGO stage | |||
Residual tumor | |||
SLCO4C1 (categorical and continuous) | 0.99% | ||
SLCO5A1 (categorical and continuous) | 5.08% | ||
SLCO1B7 | 0.32% | ||
SLCO2A1 | 1.12% | ||
ABCC2 | 0.84% | ||
ESR1 | 1.08% | ||
ABCB2/ABCB3/ABCC4/HER2 | 0.08% | ||
23.13% |
The corresponding PEVs for the final multi-variable Cox model are shown (starting from 12.80% for the model including only the three clinicopathological factors). After including all seven additional predictors, a PEV of 23.13% was reached. The categorical and continuous variables for SLCO4C1 and SLCO5A1 were used together (see Figure 2).